Volker Hoffmann, MD
Partner/OwnerDiagnostic Imaging Center
Volker Hoffmann, MD, is a Diagnostic and Interventional Radiologist and one of the three owners of Diagnostic Imaging Center, a large private imaging center.
He was a Product Manager and Medical Consultant at Strategic Marketing of the Global Business Unit Diagnostics at Schering AG, (now BayerScheringPharma) Germany. Dr. Hoffmann's main area of interest is breast imaging, optical imaging as well as MR imaging (heart, liver, and blood pool). He also has knowledge of in-licensing, business case models, and development plans for all diagnostic modalities including MR, ultrasound, CT, x-ray angiography, and partially nuclear medicine. For several years, Dr. Hoffmann was in clinical development where he was responsible for Phase I/II/III and IV trials in the US and Europe for MR and x-ray imaging agents.
(This is me - Update Profile)
| 2006 - present | Partner/Owner Diagnostic Imaging Center |
|---|---|
| 2001 - 2005 | Product Manager and Medical Advisor SCHERING AG. |
| 1996 - 2000 | Study Director GE Amersham Healthcare |
GLG Study Groups with Volker Hoffmann, MD(?)
| Study Group Name | Members |
|---|---|
| Radiologists (EU) | 234 |
| Interventional and Vascular Radiologists (EU) | 71 |
| Physicians (Germany) | 1114 |
| Diagnostic Radiologists (EU) | 136 |
GLG NewsSM Analyses by Volker Hoffmann, MD(?)
Nephrogenic systemic fibrosis is becoming a severe problem for radiologist and industry as it may prevent physicians from using gadolinium containing contrast agents fearing that they induce nephrogenic systemic fibrosis even in patients without known kidney disease. A stable contrast agent with almost...
The recent upgrade of the Computed Tomography Laser Mammography (CTLM(R)) system will only added minor details. The question whether this system without any contrast agent is of any value has not been answered so far.
Pancreatic duct imaging is currently done with a heavily weighted T2 sequence that requires water in the duct for imaging. Increased production of pancreatic juice may make imaging easier. This is however a very small niche market which by itself will not allow survival of RG1068.
GLG InstituteSM Seminars with Volker Hoffmann, MD(?)
Upcoming Seminars
Request a project with Volker Hoffmann, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms